FORGING AHEAD

Re-building Stronger

VISIT CGHD.ORG

FORGING AHEAD

Re-building Stronger

VISIT CGHD.ORG

FORGING AHEAD

Re-building Stronger

VISIT CGHD.ORG

FORGING AHEAD

Re-building Stronger

VISIT CGHD.ORG

FORGING AHEAD

Re-building Stronger

VISIT CGHD.ORG

HOW TO MAINTAIN AND ENHANCE ACCESS TO CARE FOR NON-COVID-19 CONDITIONS AND DISEASE STATES

The Center for Global Health and Development and the Crown Prince Court of Abu Dhabi, are working with UN Agencies, NGOs, investors, governments and several development finance corporations to improve access to healthcare in emerging markets by driving support for innovative partnerships and healthcare solutions that can be scaled. This work began with a series of workshops that brought together leaders and decision-makers to discuss solutions that increase access to care in emerging markets on February 22 and 23, 2021.

The workshops focused on supply chain management, workforce shortages (and the role of nurses and midwives), capacity building, health security and the innovative financing mechanisms that can be used to successfully address these issues.

Following the workshops, a multi-sectoral group of key leaders recommended the establishment of a working group to improve access to healthcare in emerging markets. The working group will provide pan-sectoral guidance to identify and refine case studies and investment models, which will be incorporated into a Financing Book of partnerships and scalable solutions.

Highlights from the discussion and more details on the Financing Book are included below.

Webinar Videos

Webinar Video: Day 1 – Panel 2

Webinar Video: Day 2 – Full Video

The Financing Book: Comments

SESSION HIGHLIGHTS

Colin Buckley
GENERAL COUNSEL AND HEAD OF EXTERNAL AFFAIRS, CDC UK

Q1: What do you see as some of the major challenges ahead of us, in terms of development finance, as it relates to partnering with multilateral agencies, governments and the private sector?

Q2: Question posed by Elizabeth Murray Executive Director, Global Patient Solutions, Gilead Sciences:
How do you see the way forward in terms of innovative financing solutions for supporting and increasing the number healthcare workers?

Watch Video

Fergus Drake Picture — Fergus Drake
CEO, CROWN AGENTS

Q1: How is Crown Agents reaching the last mile challenges in emerging markets, particularly to get populations vaccinated?

Q2: Is Crown Agents seeing anything new in terms of non-traditional supply chains for getting product out?

Watch Video

Jasper Klapwijk
BUSINESS DEVELOPMENT MANAGER, FMO

Q1: What are your thoughts on the discussion to date and what do you see as the challenges and solutions for supply chain and workforce?

Watch Video

Jayasree K. Iyer
EXECUTIVE DIRECTOR, ACCESS TO MEDICINE FOUNDATION

Q1: What are some of the particular challenges and opportunities that Access to Medicines is seeing right now in supply chain and building supply chain capacity? What steps need to be taken right now under COVID-19 to address them and how can we be planning for post COVID-19?

Q2: Today we’ve seen innovative solutions for access to medicines from a financing and platform perspective. Do you see these as potential solutions, are there other challenges that need to be addressed and how can we scale these further?

Watch Video

Jean-Philippe Syed
PRINCIPAL, DEVELOPMENT PARTNERS INTERNATIONAL

Q1: DPI is working with CDC UK on a project called Zanzibar, what are the factors that lead to this partnership? Why did a typical private equity firm like DPI want to invest in such a project?

Q2: Question posed by Andy Whitman, Senior Vice President, Government Affairs, Varian: As a technology company, we can deploy equipment, but we need a skilled workforce in order to actually reach the patients, how do we create innovative financing solutions with the private sector willing to take on some of the risk?

Watch Video

Osman Khalid Waheed
CHIEF EXECUTIVE OFFICER, FEROZSONS LABORATORIES LIMITED

Q1: As a manufacturer of medicines and supplies can you discuss the steps that are needed to obtain financing for local production, address API shortages, and get diplomatic buy-in? Can you address this to in the context on innovative solutions for health workforce and supply chain?

Q2: How do you see the role of health workforce in deploying some of these solutions on the ground?

Watch Video

Dr. Slim Slama
REGIONAL ADVISOR, NONCOMMUNICABLE DISEASE PREVENTION UNIT (NCP) AND NONCOMMUNICABLE DISEASE MANAGEMENT UNIT (NCM), WHO EASTERN MEDITERRANEAN REGIONAL OFFICE (EMRO)

Q: What role can the WHO play in some of these solutions relating to health workforce?

Watch Video

THE FINANCING BOOK

Specific case studies will be featured during the workshop discussions including those that use market shaping and programmatic techniques to address barriers and strengthen access to care. This not only increases awareness of these select innovations, but also allows for a multi-sectoral analysis of investment cases and potential for scaling. Participants will also evaluate core elements that contributed to successes and consider how lessons learned can be applied more broadly across contexts and conditions.

Each of the analyzed investment cases will be summarized in to a 4-5 page “snapshot” of the potential partnership or deal arrangement, laying out a summary of the potential opportunity, structure, details of the business strategy, current investors/partners, potential for scaling, target transaction size and instruments for financing growth, intended impact, and current stage of readiness in the opportunity/innovation cycle.

These selected summaries will then be incorporated into The Financing Book which will be circulated to investors, Ministries of Health and Finance, Development Agencies, Development Finance Institutions and foundations in CGHD’s network, which includes over 50 governments, and dozens of private investors and foundations, including those that attended the workshops.

View The Financing Book Comments